Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN)

CUSIP: 59045L106

Q1 2020 13F Holders as of 31 Mar 2020

Holder snapshot 6 signals
Share change
+4,460,347
SEC-reported price per share
$5.83
Number of holders
82
Value change
+$26,078,897
Number of buys
54
Number of sells
23
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,992,318

Security key

59045L106

Report period

Q1 2020

Institutions

82

Top holders

10

Ownership snapshot

Top reported holders of MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
NEA Management Company, LLC
Disclosed value leader
NEA Management Company, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2019
13F Highest disclosed value: $68,552,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

NEA Management Company, LLC has the largest disclosed position value at $68.55M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NEA Management Company, LLC's linked filing trail.
Disclosed position value Top 5
NEA Management Company, LLC $68.55M
Sarissa Capital Management LP $21.49M
BlackRock Finance, Inc. $14.13M
ORBIMED ADVISORS LLC $11.88M
VANGUARD GROUP INC $10.7M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
NEA Management Company, LLC
13F
Company
13F
—
denominator unverified
$68,552,000
11,963,649 shares
— 31 Dec 2019
Sarissa Capital Management LP
13F
Company
13F
—
denominator unverified
$21,487,000
3,750,000 shares
— 31 Dec 2019
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$14,126,000
2,465,319 shares
— 31 Dec 2019
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$11,880,000
2,073,319 shares
— 31 Dec 2019
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$10,699,000
1,867,264 shares
— 31 Dec 2019
VHCP Management III, LLC
13F
Company
13F
—
denominator unverified
$8,947,000
1,561,389 shares
— 31 Dec 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
82
Shares
40,118,913
Rows available
82
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q4 2025 Across Filers

Q4 2025 holders
3
Q1 2020 holders
82
Holder diff
79
Investor Q4 2025 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2025 value Q1 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .